Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Roos

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
AIDS (London, England)|January 1, 1991
Differences in clinical course in zidovudine-treated asymptomatic HIV-infected men associated with T-cell function at intakeR A Gruters, F G Terpstra, J M Lange, et al.
Journal of Virology|January 1, 1985
Immunoglobulin subclasses of antibodies to human T-cell leukemia/lymphoma virus I-associated antigens in acquired immune deficiency syndrome and lymphadenopathy syndromeJ Goudsmit, F Miedema, R J Wijngaarden-du Bois, et al.
The Journal of Infectious Diseases|June 3, 1999
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapyO Pontesilli, S Kerkhof-Garde, D W Notermans, et al.
AIDS (London, England)|November 1, 1992
Large diurnal variation in CD4 cell count and T-cell function among drug users: implications for clinical practice and epidemiological studiesG H Mientjes, E J van Ameijden, M T Roos, et al.
Journal of Neuroimmunology|May 5, 1999
Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patientsM H Rep, H M Schrijver, T van Lopik, et al.
AIDS (London, England)|November 1, 1996
Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993I P Keet, P J Veugelers, M Koot, et al.
Annals of Internal Medicine|May 1, 1993
Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDSM Koot, I P Keet, A H Vos, et al.
AIDS (London, England)|November 1, 1994
Viro-immunological studies in acute HIV-1 infectionM T Roos, N A de Leeuw, F A Claessen, et al.
AIDS (London, England)|February 1, 1989
Antibody response to a synthetic peptide covering a LAV-1/HTLV-IIIB neutralization epitope and disease progressionC A Boucher, F de Wolf, J T Houweling, et al.
The Journal of Infectious Diseases|November 7, 1998
In vivo delayed-type hypersensitivity skin test anergy in human immunodeficiency virus type 1 infection is associated with T cell nonresponsiveness in vitroJ J Maas, M T Roos, I P Keet, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
AIDS (London, England)|January 1, 1991
Differences in clinical course in zidovudine-treated asymptomatic HIV-infected men associated with T-cell function at intakeR A Gruters, F G Terpstra, J M Lange, et al.
Journal of Virology|January 1, 1985
Immunoglobulin subclasses of antibodies to human T-cell leukemia/lymphoma virus I-associated antigens in acquired immune deficiency syndrome and lymphadenopathy syndromeJ Goudsmit, F Miedema, R J Wijngaarden-du Bois, et al.
The Journal of Infectious Diseases|June 3, 1999
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapyO Pontesilli, S Kerkhof-Garde, D W Notermans, et al.
AIDS (London, England)|November 1, 1992
Large diurnal variation in CD4 cell count and T-cell function among drug users: implications for clinical practice and epidemiological studiesG H Mientjes, E J van Ameijden, M T Roos, et al.
Journal of Neuroimmunology|May 5, 1999
Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patientsM H Rep, H M Schrijver, T van Lopik, et al.
AIDS (London, England)|November 1, 1996
Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993I P Keet, P J Veugelers, M Koot, et al.
Annals of Internal Medicine|May 1, 1993
Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDSM Koot, I P Keet, A H Vos, et al.
AIDS (London, England)|November 1, 1994
Viro-immunological studies in acute HIV-1 infectionM T Roos, N A de Leeuw, F A Claessen, et al.
AIDS (London, England)|February 1, 1989
Antibody response to a synthetic peptide covering a LAV-1/HTLV-IIIB neutralization epitope and disease progressionC A Boucher, F de Wolf, J T Houweling, et al.
The Journal of Infectious Diseases|November 7, 1998
In vivo delayed-type hypersensitivity skin test anergy in human immunodeficiency virus type 1 infection is associated with T cell nonresponsiveness in vitroJ J Maas, M T Roos, I P Keet, et al.
Pageof 8